1010173

Romark Laboratories, L.C. — FEI 3003966280

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 8, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Tampa, FL (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
673021 CFR 314.80(b)Failure to develop written procedures
683221 CFR 314.80(c)(2)Late submission of annual safety reports